Loci polymorphisms of the APOBEC3G gene in HIV type 1-infected Brazilians

AIDS Research and Human Retroviruses

Volumn 27, Issue 2, 2011, Pages 137-141

  Bizinoto, Maria Clara ^a   Leal, Élcio ^b   Diaz, Ricardo Sobhie ^a   Janini, Luiz Mário ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CD4 ANTIGEN;

ARTICLE; BRAZIL; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS GENE;

BRAZIL; CYTIDINE DEAMINASE; HIV INFECTIONS; HIV-1; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79951707694     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0146     Document Type: Article

References (37)

1. Chiu YL and Greene WC: The APOBEC3 cytidine deaminases: An innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu Rev Immunol 2008;26:317-353. (Pubitemid 351600379)
2. Fellay J, Ge D, Shianna KV, et al.: Common genetic variation and the control of HIV-1 in humans. PLoS Genet 2009;5: e1000791.
3. LaRue RS, Jonsson SR, Silverstein KA, et al.: The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals. BMC Mol Biol 2008;9:104.
4. An P, Bleiber G, Duggal P, et al.: APOBEC3G genetic variants and their influence on the progression to AIDS. J Virol 2004;78:11070-11076. (Pubitemid 39299647)
5. Pace C, Keller J, Nolan D, et al.: Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation. J Virol 2006;80:9259-9269. (Pubitemid 44359998)
6. Luo K, Liu B, Xiao Z, et al.: Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging. J Virol 2004;78: 11841-11852. (Pubitemid 39390771)
7. Bishop KN, Holmes RK, Sheehy AM, et al.: APOBECmediated editing of viral RNA. Science 2004;305:645.
8. Lecossier D, Bouchonnet F, Clavel F, et al.: Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 2003; 300:1112. (Pubitemid 36583087)
9. Mangeat B, Turelli P, Caron G, et al.: Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003;424:99-103. (Pubitemid 36834849)
10. Zhang H, Yang B, Pomerantz RJ, et al.: The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 2003;424:94-98. (Pubitemid 36834848)
11. Liddament MT, Brown WL, Schumacher AJ, et al.: APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo. Curr Biol 2004;14:1385-1391. (Pubitemid 39081642)
12. Yu X, Yu Y, Liu B, et al.: Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 2003;302:1056-1060. (Pubitemid 37386201)
13. Kobayashi M, Takaori-Kondo A, Miyauchi Y, et al.: Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function. J Biol Chem 2005;280:18573-18578. (Pubitemid 41379555)
14. Marin M, Rose KM, Kozak SL, et al.: HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med 2003;9:1398-1403. (Pubitemid 37466189)
15. Sheehy AM, Gaddis NC, and Malim MH: The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 2003;9:1404-1407. (Pubitemid 37466190)
16. Mehle A, Wilson H, Zhang C, et al.: Identification of an APOBEC3G binding site in human immunodeficiency virus type 1 Vif and inhibitors of Vif-APOBEC3G binding. J Virol 2007;81:13235-13241. (Pubitemid 350156961)
17. Donahue JP, Vetter ML, Mukhtar NA, et al.: The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation. Virology 2008;377:49-53.
18. Do H, Vasilescu A, Diop G, et al.: Exhaustive genotyping of the CEM15 (APOBEC3G) gene and absence of association with AIDS progression in a French cohort. J Infect Dis 2005;191:159-163. (Pubitemid 40096372)
19. Valcke HS, Bernard NF, Bruneau J, et al.: APOBEC3G genetic variants and their association with risk of HIV infection in highly exposed Caucasians. AIDS 2006;20:1984-1986. (Pubitemid 44427620)
20. Rathore A, Chatterjee A, Yamamoto N, et al.: Absence of H186R polymorphism in exon 4 of the APOBEC3G gene among North Indian individuals. Genet Test 2008;12:453-456.
21. Conticello SG: The AID/APOBEC family of nucleic acid mutators. Genome Biol 2008;9:229.
22. Parra FC, Amado RC, Lambertucci JR, et al.: Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA 2003;100:177-182. (Pubitemid 36078048)
23. Lewontin RC: On measures of gametic disequilibrium. Genetics 1988;120:849-852. (Pubitemid 18260517)
24. Sans M: Admixture studies in Latin America: From the 20th to the 21st century. Hum Biol 2000;72:155-177. (Pubitemid 30132304)
25. Wang S, Ray N, Rojas W, et al.: Geographic patterns of genome admixture in Latin American Mestizos. PLoS Genet 2008;4:e1000037.
26. Gaspar PA, Hutz MH, Salzano FM, et al.: TP53 polymorphisms and haplotypes in South Amerindians and neo- Brazilians. Ann Hum Biol 2001;28:184-194. (Pubitemid 32232391)
27. Lins TC, Vieira RG, Abreu BS, et al.: Genetic composition of Brazilian population samples based on a set of twenty-eight ancestry informative SNPs. Am J Hum Biol 2009;22:187-192.
28. Villanova FE, Andrade PM, Otsuka AY, et al.: Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma. Steroids 2006;71:960-965. (Pubitemid 44573298)
29. Vazquez-Perez JA, Ormsby CE, Hernandez-Juan R, et al.: APOBEC3G mRNA expression in exposed seronegative and early stage HIV infected individuals decreases with removal of exposure andwith disease progression. Retrovirology 2009;6:23.
30. Reddy K, Winkler CA, Werner L, et al.: APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load. AIDS 2010;24:195-204.
31. Kuiken CL, de Jong JJ, Baan E, et al.: Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype. J Virol 1992;66:5704.
32. Leal E, Silva WP, Sucupira MC, et al.: Molecular and structural characterization of HIV-1 subtype B Brazilian isolates with GWGR tetramer at the tip of the V3-loop. Virology 2008;381:222-229.
33. Morgado MG, Sabino EC, Shpaer EG, et al.: V3 region polymorphisms in HIV-1 from Brazil: Prevalence of subtype B strains divergent from North American/European prototype and detection of subtype F. AIDS Res Hum Retroviruses 1994;10:569-576. (Pubitemid 24186727)
34. Ndung'u T, Renjifo B, Novitsky VA, et al.: Molecular cloning and biological characterization of full-length HIV-1 subtype C from Botswana. Virology 2000;278:390-399. (Pubitemid 32012774)
35. Sanabani S, Neto WK, de Sa Filho DJ, et al.: Full-length genome analysis of human immunodeficiency virus type 1 subtype C in Brazil. AIDS Res Hum Retroviruses 2006;22:171-176. (Pubitemid 43277153)
36. Santoro-Lopes G, Harrison LH, Tavares MD, et al.: HIV disease progression and V3 serotypes in Brazil: Is B different from B-Br? AIDS Res Hum Retroviruses 2000;16:953-958. (Pubitemid 30436493)
37. Diaz RS, Leal E, Sanabani S, et al.: Selective regimes and evolutionary rates of HIV-1 subtype B V3 variants in the Brazilian epidemic. Virology 2008;381:184-193.